Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.975,93
1,10%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire ETFs U.S.A. AMEX Emles at Home ETF (LIV) Emles at Home ETF (LIV) Notizie

LIV

Emles at Home ETF (LIV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:LIV
DataOraFonteTitoloSimboloCompagnia
16/09/202223:00PR Newswire (US)Emles Advisors Announces Closure of Six FundsAMEX:LIVEmles at Home ETF
13/12/200716:15Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
19/11/200718:52Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:LIVEmles at Home ETF
15/11/200720:16Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:LIVEmles at Home ETF
13/11/200712:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other)AMEX:LIVEmles at Home ETF
08/11/200716:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filingAMEX:LIVEmles at Home ETF
01/10/200716:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
15/06/200616:09Business WireSamaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0AMEX:LIVEmles at Home ETF
30/05/200614:59Business WireSamaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy TrialAMEX:LIVEmles at Home ETF
23/05/200615:22Business WireSamaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;AMEX:LIVEmles at Home ETF
02/05/200615:15Business WireSamaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01AAMEX:LIVEmles at Home ETF
25/04/200614:00Business WireSIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with ScAMEX:LIVEmles at Home ETF
13/04/200619:13Business WireBio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This YearAMEX:LIVEmles at Home ETF
06/04/200614:30Business WireLIV to Host Annual Shareholders MeetingAMEX:LIVEmles at Home ETF
04/04/200615:15Business WireSamaritan's Marketing Authorization Application For Amphocil Approved in GreeceAMEX:LIVEmles at Home ETF
30/03/200616:15Business WireSamaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International ConferenceAMEX:LIVEmles at Home ETF
28/03/200616:27Business WireNew Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market WorldwiAMEX:LIVEmles at Home ETF
23/03/200615:30Business WireSamaritan is the Little Biotech That Could Be Remembered for Alzheimer'sAMEX:LIVEmles at Home ETF
22/03/200605:01Business WireCORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
21/03/200616:29Business WireSamaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
09/03/200614:00Business WireUPDATE: Samaritan Kicks Off Follow-On HIV StudyAMEX:LIVEmles at Home ETF
01/03/200614:00Business WireDistinguished Cancer Drug Developer Joins Samaritan Scientific Advisory BoardAMEX:LIVEmles at Home ETF
28/02/200614:00Business WireSamaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective PropertiesAMEX:LIVEmles at Home ETF
24/02/200613:00Business WireSIS Foundation Poses CSI Bio-Future Bus as Solution to Time Magazine's, Is America Flunking Science?AMEX:LIVEmles at Home ETF
14/02/200611:00Business WireSamaritan Devoted to Pipeline SuccessAMEX:LIVEmles at Home ETF
09/02/200615:58Business WireSamaritan Announces $40 Million Common Stock Purchase Agreement and Compliance with AMEX Additional Share RegistrationAMEX:LIVEmles at Home ETF
02/02/200614:00Business WireNew Innovative Drugs to Treat Mitochondrial Diseases Exclusively Licensed to SamaritanAMEX:LIVEmles at Home ETF
01/02/200614:00Business WireSamaritan Pharmaceuticals' Subsidiary Certified as a CDE for New Market Tax Credit ProgramAMEX:LIVEmles at Home ETF
18/01/200614:00Business WireGolden Globe/Academy Award Winner John Williams and Boston Pops Concert Benefiting the Samaritan Foundation Tentatively ScheduleAMEX:LIVEmles at Home ETF
13/01/200614:00Business WireNew FDA Rules Expected to Expedite Testing of Samaritan's DrugsAMEX:LIVEmles at Home ETF
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:LIV

La tua Cronologia

TG
OC5
Cochlear
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network